Literature DB >> 10807978

Spectrophotometric assay for serum platelet-activating factor acetylhydrolase activity.

T Kosaka1, M Yamaguchi, Y Soda, T Kishimoto, A Tago, M Toyosato, K Mizuno.   

Abstract

We developed a spectrophotometric assay for serum platelet-activating factor acetylhydrolase (PAF-AH, EC 3.1.1.47.) activity using a platelet-activating factor (PAF) analogue with a 4-nitrophenyl group as substrate. PAF-AH hydrolyzes the sn-2 position of the substrate ¿1-myristoyl-2-(p-nitrophenylsuccinyl)phosphatidylcholine, producing p-nitrophenyl succinate. This liberation was spectrophotometrically monitored and the activity determined from the change in absorption. The assay does not require radioisotopes and is applicable to an automatic analyzer. Utilizing this assay with an automatic analyzer, it is possible to measure the activities of thousands of samples in a few hours with excellent precision (CV 0.5%, n=30) and high correlation (r=0.979, n=100) with the results of a conventional radioisotopic assay. The assay should be particularly useful for clinical diagnostics.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10807978     DOI: 10.1016/s0009-8981(00)00216-3

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  15 in total

1.  Determination of phospholipase activity of PAF acetylhydrolase.

Authors:  Diana M Stafforini; Thomas M McIntyre
Journal:  Free Radic Biol Med       Date:  2012-05-29       Impact factor: 7.376

2.  Age as a modulator of inflammatory cardiovascular risk factors.

Authors:  Erdembileg Anuurad; Byambaa Enkhmaa; Zeynep Gungor; Wei Zhang; Russell P Tracy; Thomas A Pearson; Kyoungmi Kim; Lars Berglund
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-06-23       Impact factor: 8.311

3.  Association of lipoprotein-associated phospholipase A2 with coronary artery disease in African-Americans and Caucasians.

Authors:  Erdembileg Anuurad; Zeynep Ozturk; Byambaa Enkhmaa; Thomas A Pearson; Lars Berglund
Journal:  J Clin Endocrinol Metab       Date:  2010-03-01       Impact factor: 5.958

4.  Effect of splenectomy and autologous spleen transplantation on the serum platelet-activating factor acetylhydrolase (PAF-AH) activity and acute phase response (APR) in a porcine model.

Authors:  Romana Turk; Drazen Vnuk; Ante Svetina; Zlata Flegar-Mestrić; Zlata Flegar-Mestri; Mirna Robić; Mirna Robi; Nenad Turk; Vilim Staresina; Vlatko Rumenjak; Dubravka Juretić; Dubravka Jureti
Journal:  Inflammation       Date:  2009-10       Impact factor: 4.092

5.  Lipoprotein-associated phospholipase A2 activity and risk of recurrent stroke.

Authors:  Mitchell S V Elkind; Wanling Tai; Kristen Coates; Myunghee C Paik; Ralph L Sacco
Journal:  Cerebrovasc Dis       Date:  2008-11-15       Impact factor: 2.762

6.  PLA2G7 genotype, lipoprotein-associated phospholipase A2 activity, and coronary heart disease risk in 10 494 cases and 15 624 controls of European Ancestry.

Authors:  Juan P Casas; Ewa Ninio; Andrie Panayiotou; Jutta Palmen; Jackie A Cooper; Sally L Ricketts; Reecha Sofat; Andrew N Nicolaides; James P Corsetti; F Gerry R Fowkes; Ioanna Tzoulaki; Meena Kumari; Eric J Brunner; Mika Kivimaki; Michael G Marmot; Michael M Hoffmann; Karl Winkler; Winfred März; Shu Ye; Heide A Stirnadel; S Matthijs Boekholdt; Kay-Tee Khaw; Steve E Humphries; Manjinder S Sandhu; Aroon D Hingorani; Philippa J Talmud
Journal:  Circulation       Date:  2010-05-17       Impact factor: 29.690

7.  Evaluation of lipoprotein-associated phospholipase A2 in healthy Chinese Han adult serum.

Authors:  Li-Min Feng; Guo-Fang Feng; Yu Chen
Journal:  Lipids Health Dis       Date:  2014-01-07       Impact factor: 3.876

8.  Attenuated age-impact on systemic inflammatory markers in the presence of a metabolic burden.

Authors:  Anuurad Erdembileg; Annie Mirsoian; Byambaa Enkhmaa; Wei Zhang; Laurel A Beckett; William J Murphy; Lars F Berglund
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

9.  Biomarkers and their involvement in the early diagnosis of right ventricular dysfunction in type 2 Diabetes Mellitus.

Authors:  O Vittos; B Toana; A Vittos
Journal:  J Med Life       Date:  2012-03-05

10.  Clinical application of elevated platelet-activating factor acetylhydrolase in patients with hepatitis B.

Authors:  Limin Feng; Ying Zhao; Guofang Feng; Yu Chen
Journal:  Lipids Health Dis       Date:  2014-06-28       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.